Market header image

Bulletins

You are here

2016-0819 - Suspension - Pivotal Therapeutics Inc. (PVO)

August 17, 2016

Pivotal Therapeutics Inc. is in default of CSE requirements. Effective at market close, Pivotal Therapeutics, currently the subject of a Cease Trade Order, will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.

Date: Effective market close, August 17, 2016
Symbol: PVO

If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Advertisement

Publicité

Latest CSE News

Upcoming Events

04_03_IIAC_Compliance_Operations_Symposium_Website

IIAC Compliance & Operations Symposium

Wednesday, April 3, 2019 (All day)
04_03_FFCON19_FEARLESS_Website_v2

FFCON19 FEARLESS

Wednesday, April 3, 2019 (All day) to Thursday, April 4, 2019 (All day)

Advertisement

Publicité